Literature DB >> 17939622

Uncontrolled type 1 diabetes mellitus and endothelial dysfunction in adolescents.

Yael Shachor-Meyouhas1, Giora Pillar, Naim Shehadeh.   

Abstract

BACKGROUND: Diabetes mellitus is associated with microvascular and macrovascular diseases, potentially manifested as endothelial dysfunction. In adults with type 2 diabetes the haptoglobin genotype 1-1 has been shown to have a protective role in inhibiting the development of complications. Although complications from type 1 diabetes are infrequent during childhood, endothelial dysfunction, which is an early marker of vascular complications, may occur.
OBJECTIVES: To evaluate endothelial function in adolescents with type 1 diabetes before the development of complications and to test for potential relationships between endothelial dysfunction and haptoglobin genotype.
METHODS: The study group comprised 15 adolescents with type 1 diabetes. All underwent a general physical examination, diabetes control evaluation (including HbA1c levels), endothelial function assessment and haptoglobin genotype determination.
RESULTS: There was a significant negative correlation between HbA1c levels and endothelial function (r = -0.48, P < 0.05), and HbA1c was significantly higher in patients with endothelial dysfunction than in those with normal endothelial function (9.9 +/- 2.2 vs. 7.7 +/- 1.0 mg/dl, P < 0.05). In addition, there was a tendency toward a positive correlation between high density lipoprotein and endothelial function (r = 0.4, P < 0.1). There was no correlation between the haptoglobin genotype and endothelial function.
CONCLUSIONS: These results show that even in patients without complications, uncontrolled type 1 diabetes is associated with endothelial dysfunction, which may lead to microvascular complications in the future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17939622

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  8 in total

1.  Assessing endothelial vasodilator function with the Endo-PAT 2000.

Authors:  Andrea L Axtell; Fatemeh A Gomari; John P Cooke
Journal:  J Vis Exp       Date:  2010-10-15       Impact factor: 1.355

2.  Measurement of peripheral arterial tonometry in patients with diabetic foot ulcers during courses of hyperbaric oxygen treatment.

Authors:  Morten Hedetoft; Niels V Olsen; Isabel G Smidt-Nielsen; Anna M Wahl; Anita Bergström; Anders Juul; Ole Hyldegaard
Journal:  Diving Hyperb Med       Date:  2020-03-31       Impact factor: 0.887

3.  Physical fitness, dietary intake, and metabolic control in adolescents with type 1 diabetes.

Authors:  Sara Fleet Michaliszyn; Gabriel Q Shaibi; Lauretta Quinn; Cynthia Fritschi; Melissa Spezia Faulkner
Journal:  Pediatr Diabetes       Date:  2009-04-09       Impact factor: 4.866

4.  Evaluation of the EndoPAT as a Tool to Assess Endothelial Function.

Authors:  M Moerland; A J Kales; L Schrier; M G J van Dongen; D Bradnock; J Burggraaf
Journal:  Int J Vasc Med       Date:  2012-02-14

5.  Endothelial function in children with a history of henoch schonlein purpura.

Authors:  Yonatan Butbul Aviel; Lotem Dafna; Giora Pilar; Riva Brik
Journal:  Pediatr Rheumatol Online J       Date:  2017-01-14       Impact factor: 3.054

6.  Ethnic Disparities in Endothelial Function and Its Cardiometabolic Correlates: The Pathobiology of Prediabetes in A Biracial Cohort Study.

Authors:  Ibiye Owei; Nkiru Umekwe; Hanan Mohamed; Sotonte Ebenibo; Jim Wan; Sam Dagogo-Jack
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-13       Impact factor: 5.555

7.  Assessment of Microvascular Function in Children and Adolescents with Diabetes and Obesity.

Authors:  Elna Kochummen; Vatcharapan Umpaichitra; Albara Marwa; Krittika Joshi; Vivian L Chin; Sheila Perez-Colon
Journal:  Int J Endocrinol Metab       Date:  2019-12-29

8.  Preserved endothelial function in young adults with type 1 diabetes.

Authors:  Martin Heier; Cathrine Nygaard Espeland; Cathrine Brunborg; Ingebjørg Seljeflot; Hanna Dis Margeirsdottir; Kristian F Hanssen; Drude Fugelseth; Knut Dahl-Jørgensen
Journal:  PLoS One       Date:  2018-10-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.